Meghmani Organics Limited AI Stock Analysis
Want to see IN:MOL full AI Analyst Report?
Meghmani Organics Limited (MOL) AI Stock Analysis
Meghmani Organics Limited
(NSE:MOL)
The overall score is constrained by weak financial performance and an expensive valuation. The company's thin profitability and high P/E ratio are significant risks. However, strong bullish technical momentum and a stable balance sheet provide some support, lifting the score from the lower end of the range.
Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 13.86B
- Dividend Yield
- ―
- Average Volume (3M)
- 98.17K
- Price to Earnings (P/E)
- 16.2
- Beta (1Y)
- 1.34
- Revenue Growth
- -5.19%
- EPS Growth
- 118.24%
- Country
- India
- Employees
- 1,154
- Sector
- General
- Sector Strength
- 55
- Industry
- Agricultural Inputs
Meghmani Organics Limited Business Overview & Revenue Model
Company Description
Meghmani Organics Limited, founded in 1986 and headquartered in Ahmedabad, India, operates as a producer and supplier of an extensive range of pigments and agrochemical products, catering to markets both within India and globally. The company's pigme...
Meghmani Organics Limited Financial Statement Overview
Summary
Financial performance is mixed. The company returned to profitability and generated positive free cash flow, but revenue is volatile and margins remain thin. The balance sheet is stable with moderate leverage, though return on equity is low. Overall, recent recovery is encouraging but sustainability is unproven.
Income Statement
45NeutralBalance Sheet
60NeutralCash Flow
55Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.03B | 21.74B | 21.24B | 15.48B | 25.28B | 24.73B |
| Gross Profit | 6.70B | 5.93B | 8.60B | 4.44B | 9.30B | 9.41B |
| EBITDA | 2.99B | 2.73B | 1.87B | 119.50M | 4.10B | 4.81B |
| Net Income | 642.50M | 287.39M | -106.01M | -1.06B | 2.38B | 3.04B |
Balance Sheet | ||||||
| Total Assets | 0 | 30.21B | 30.85B | 30.40B | 31.98B | 27.98B |
| Cash, Cash Equivalents and Short-Term Investments | 264.88M | 264.88M | 227.24M | 330.74M | 1.52B | 117.22M |
| Total Debt | 0 | 7.26B | 8.29B | 8.37B | 8.24B | 4.99B |
| Total Liabilities | -15.45B | 14.76B | 15.70B | 15.12B | 15.29B | 13.31B |
| Stockholders Equity | 15.45B | 15.45B | 15.15B | 15.28B | 16.69B | 14.66B |
Cash Flow | ||||||
| Free Cash Flow | 422.76M | 975.10M | -226.88M | -165.29M | -2.61B | -1.79B |
| Operating Cash Flow | 668.34M | 1.43B | 662.22M | 2.50B | 2.04B | 648.32M |
| Investing Cash Flow | -211.79M | -458.42M | 309.70M | -1.78B | -4.18B | -1.33B |
| Financing Cash Flow | -373.49M | -1.04B | -913.88M | -854.77M | 2.34B | 577.19M |
Meghmani Organics Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Positive. The current price of 55.23 is above the 20-day moving average (MA) of 55.05, below the 50-day MA of 58.56, and above the 200-day MA of 53.38, indicating a neutral trend. The MACD of -0.85 indicates Negative momentum. The RSI at 47.87 is Neutral, neither overbought nor oversold. The STOCH value of 42.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MOL.
Meghmani Organics Limited Peers Comparison
Overall Rating
IN:DHANUKA73Outperform
IN:SHARDACROP71Outperform
IN:IPL60Neutral
IN:PIIND58Neutral
IN:UPL58Neutral
IN:MOL57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | INR 40.58B | 14.53 | ― | 0.22% | -0.06% | 0.75% | |
| 71Outperform | INR 64.62B | 10.40 | ― | 2.03% | 17.28% | 42.45% | |
| 60Neutral | INR 13.94B | 12.72 | ― | 0.63% | 2.89% | -9.47% | |
| 58Neutral | INR 266.64B | 30.07 | ― | 0.57% | -14.95% | -41.96% | |
| 58Neutral | INR 466.87B | 24.85 | ― | 1.08% | 10.33% | -14.32% | |
| 57Neutral | INR 14.07B | 16.20 | ― | ― | -5.19% | 118.24% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:MOL | Meghmani Organics Limited | 55.23 | -16.72 | -23.24% | |
| IN:DHANUKA | Dhanuka Agritech Limited | 908.30 | -358.31 | -28.29% | |
| IN:IPL | India Pesticides Ltd. | 119.00 | -61.53 | -34.08% | |
| IN:PIIND | PI Industries Limited | 1742.55 | -1799.89 | -50.81% | |
| IN:SHARDACROP | Sharda Cropchem Ltd. | 740.50 | -19.27 | -2.54% | |
| IN:UPL | UPL Limited | 554.00 | -197.97 | -26.33% |
Meghmani Organics Limited Corporate Events
Meghmani Organics Announces 7th AGM and E-Voting Arrangements
Meghmani Organics Limited has notified the stock exchanges that it has published newspaper advertisements announcing its seventh Annual General Meeting for the financial year 2025-26. The AGM will be conducted via video conferencing or other audio-vi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 25, 2026
